Leukemia cutis in accelerated chronic lymphocytic leukemia: successful treatment with venetoclax and rituximab

Ann Hematol. 2022 Jun;101(6):1387-1392. doi: 10.1007/s00277-022-04753-7. Epub 2022 Feb 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / complications
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Rituximab / therapeutic use
  • Sulfonamides / therapeutic use

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Sulfonamides
  • Rituximab
  • venetoclax